These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17136583)

  • 1. Autonomic side effects of Botulinum toxin Type B intravesical injections: report of 4 cases and review of the literature.
    Ghei M; Maraj BH; Nathan S; Malone-Lee J; Miller R
    Int Urol Nephrol; 2006; 38(3-4):543-4. PubMed ID: 17136583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial.
    Ghei M; Maraj BH; Miller R; Nathan S; O'Sullivan C; Fowler CJ; Shah PJ; Malone-Lee J
    J Urol; 2005 Nov; 174(5):1873-7; discussion 1877. PubMed ID: 16217327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis.
    Dressler D; Benecke R
    Eur Neurol; 2003; 49(1):34-8. PubMed ID: 12464716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New therapeutic options for refractory neurogenic detrusor overactivity.
    Giannantoni A; Mearini E; Di Stasi SM; Costantini E; Zucchi A; Mearini L; Fornetti P; Del Zingaro M; Navarra P; Porena M
    Minerva Urol Nefrol; 2004 Mar; 56(1):79-87. PubMed ID: 15195033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuation rates and inter-injection interval for repeated intravesical botulinum toxin type A injections for detrusor overactivity.
    Veeratterapillay R; Harding C; Teo L; Vasdev N; Abroaf A; Dorkin TJ; Pickard RS; Hasan T; Thorpe AC
    Int J Urol; 2014 Feb; 21(2):175-8. PubMed ID: 23819724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study.
    Giannantoni A; Di Stasi SM; Stephen RL; Bini V; Costantini E; Porena M
    J Urol; 2004 Jul; 172(1):240-3. PubMed ID: 15201783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of botulinum toxin on detrusor overactivity induced by intravesical adenosine triphosphate and capsaicin in a rat model.
    Atiemo H; Wynes J; Chuo J; Nipkow L; Sklar GN; Chai TC
    Urology; 2005 Mar; 65(3):622-6. PubMed ID: 15780404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [First use of botulinum toxin type B in ENT patients with secondary therapy failure of botulinum toxin type A].
    Guntinas-Lichius O
    HNO; 2004 Jan; 52(1):53-6. PubMed ID: 14740116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autonomic function after botulinum toxin type A or B: a double-blind, randomized trial.
    Tintner R; Gross R; Winzer UF; Smalky KA; Jankovic J
    Neurology; 2005 Sep; 65(5):765-7. PubMed ID: 16157918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in injection pain with botulinum toxin type B further diluted using saline with preservative: a double-blind, randomized controlled trial.
    van Laborde S; Dover JS; Moore M; Stewart B; Arndt KA; Alam M
    J Am Acad Dermatol; 2003 Jun; 48(6):875-7. PubMed ID: 12789177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin-A injections into neurogenic overactive bladder--to include or exclude the trigone? A prospective, randomized, controlled trial.
    Abdel-Meguid TA
    J Urol; 2010 Dec; 184(6):2423-8. PubMed ID: 20952003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin a versus placebo for refractory detrusor overactivity in women: a randomised blinded placebo-controlled trial of 240 women (the RELAX study).
    Tincello DG; Kenyon S; Abrams KR; Mayne C; Toozs-Hobson P; Taylor D; Slack M
    Eur Urol; 2012 Sep; 62(3):507-14. PubMed ID: 22236796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of effectiveness of detrusor, suburothelial and bladder base injections of botulinum toxin a for idiopathic detrusor overactivity.
    Kuo HC
    J Urol; 2007 Oct; 178(4 Pt 1):1359-63. PubMed ID: 17706718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder instillation of liposome encapsulated onabotulinumtoxina improves overactive bladder symptoms: a prospective, multicenter, double-blind, randomized trial.
    Chuang YC; Kaufmann JH; Chancellor DD; Chancellor MB; Kuo HC
    J Urol; 2014 Dec; 192(6):1743-9. PubMed ID: 25046622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A day case technique for administration of intradetrusor Botulinum toxin B under sedo-analgesia in neuropathic and non-neuropathic detrusor overactivity: Endoscopic Neurostabilisation (ENS).
    Ghei M; Nathan S; Maraj BH; Malone-Lee JG; Miller R
    Int Urol Nephrol; 2005; 37(3):471-2. PubMed ID: 16307321
    [No Abstract]   [Full Text] [Related]  

  • 16. The case for bladder botulinum toxin application.
    Kim DK; Thomas CA; Smith C; Chancellor MB
    Urol Clin North Am; 2006 Nov; 33(4):503-10, ix. PubMed ID: 17011386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Initial experiences with clinical use of botulinum toxin type B].
    Dressler D; Benecke R
    Nervenarzt; 2002 Feb; 73(2):194-8. PubMed ID: 11975099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary results of botulinum toxin A switch after first detrusor injection failure as a treatment of neurogenic detrusor overactivity.
    Peyronnet B; Roumiguié M; Castel-Lacanal E; Guillotreau J; Malavaud B; Marque P; Rischmann P; Gamé X
    Neurourol Urodyn; 2016 Feb; 35(2):267-70. PubMed ID: 25524826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravesical treatment of bladder pain syndrome/interstitial cystitis: from the conventional regimens to the novel botulinum toxin injections.
    Dellis A; Papatsoris AG
    Expert Opin Investig Drugs; 2014 Jun; 23(6):751-7. PubMed ID: 24749738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of intravesical botulinum toxin-A injections in women with idiopathic overactive bladder symptoms.
    Marcelissen TA; Rahnama'i MS; Snijkers A; Schurch B; De Vries P
    World J Urol; 2017 Feb; 35(2):307-311. PubMed ID: 27272312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.